View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Tislelizumab 200 / Carboplatin 5 / Etoposide 100, Small Cell Lung Cancer, Cycle 1-4
Protocol-ID: 2915 V1.0 (Mini), TISL200/CRBP5/ETOP100, SCLC, C1-4Indication(s)
- Lung Carcinoma, Small Cell; ICD-10 C34.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 20.05.2025